Optimal treatment levels in cancer therapy

Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design.

Neurology·2011

STRUCTURE AND DEVELOPMENT OF VIRUSES OBSERVED IN THE ELECTRON MICROSCOPE : IV. VIRUSES OF THE RI-APC GROUP.

The Journal of biophysical and biochemical cytology·2009

QUANTITATIVE EXPERIMENTS WITH ANTIBODIES TO A SPECIFIC PRECIPITATE : III. ANTIGENIC PROPERTIES OF HORSE SERUM FRACTIONS ISOLATED BY ELECTROPHORESIS AND BY ULTRACENTRIFUGATION.

The Journal of experimental medicine·2009

ELECTROPHORETIC STUDY OF ANTIVIRAL SERA.

The Journal of experimental medicine·2009

Oxidative stress pathways highlighted in tumor cell immortalization: association with breast cancer outcome.

Oncogene·2007

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

The Cochrane database of systematic reviews·2007

Beyond risk factors: A capacity framework for cancer survivorship research.

Cancer·2026

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Cancer·2026

Practical considerations for the use of incretin mimetics in patients with neuroendocrine neoplasms: An expert consensus statement.

Cancer·2026

Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.

Cancer·2026

Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

Cancer·2026

Disease-free survival as a surrogate outcome for localized kidney cancer-A systematic review and meta-analysis.

Cancer·2026

Clinical management of adverse events in patients with advanced HER2+ metastatic breast cancer treated with tucatinib, trastuzumab, and capecitabine.

The oncologist·2026

Treatment Initiation of Definitive Radiotherapy in Patients With Locally Advanced Head and Neck Cancer.

Cancer control : journal of the Moffitt Cancer Center·2026

[Retracted] Restoration of the tumor‑suppressor function to mutant p53 by Ganoderma lucidum polysaccharides in colorectal cancer cells.

Oncology reports·2026

Octreotide as Adjunctive Therapy for Catecholamine-Secreting Pheochromocytoma and Paraganglioma.

The Journal of clinical endocrinology and metabolism·2026

Zanubrutinib versus fludarabine, cyclophosphamide and rituximab in fit, treatment-naïve patients with chronic lymphocytic leukemia: a matching-adjusted indirect comparison.

Journal of comparative effectiveness research·2026

Prognosis of Extramedullary Disease in Chinese Newly Diagnosed Multiple Myeloma Patients Treated With Novel Agents-Based Induction Therapy.

Cancer medicine·2026

Related Experiment Videos

Optimal treatment levels in cancer therapy

Related Concept Videos

Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design.

STRUCTURE AND DEVELOPMENT OF VIRUSES OBSERVED IN THE ELECTRON MICROSCOPE : IV. VIRUSES OF THE RI-APC GROUP.

QUANTITATIVE EXPERIMENTS WITH ANTIBODIES TO A SPECIFIC PRECIPITATE : III. ANTIGENIC PROPERTIES OF HORSE SERUM FRACTIONS ISOLATED BY ELECTROPHORESIS AND BY ULTRACENTRIFUGATION.

ELECTROPHORETIC STUDY OF ANTIVIRAL SERA.

Oxidative stress pathways highlighted in tumor cell immortalization: association with breast cancer outcome.

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Beyond risk factors: A capacity framework for cancer survivorship research.

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Practical considerations for the use of incretin mimetics in patients with neuroendocrine neoplasms: An expert consensus statement.

Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.

Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

Disease-free survival as a surrogate outcome for localized kidney cancer-A systematic review and meta-analysis.

Clinical management of adverse events in patients with advanced HER2+ metastatic breast cancer treated with tucatinib, trastuzumab, and capecitabine.

Treatment Initiation of Definitive Radiotherapy in Patients With Locally Advanced Head and Neck Cancer.

[Retracted] Restoration of the tumor‑suppressor function to mutant p53 by Ganoderma lucidum polysaccharides in colorectal cancer cells.

Octreotide as Adjunctive Therapy for Catecholamine-Secreting Pheochromocytoma and Paraganglioma.

Zanubrutinib versus fludarabine, cyclophosphamide and rituximab in fit, treatment-naïve patients with chronic lymphocytic leukemia: a matching-adjusted indirect comparison.

Prognosis of Extramedullary Disease in Chinese Newly Diagnosed Multiple Myeloma Patients Treated With Novel Agents-Based Induction Therapy.

Related Experiment Videos

Optimal treatment levels in cancer therapy

Related Concept Videos

Related Articles